Citation sources

Updated weekly. Details via Crossref

Crossref	Scopus	Google Scholar
27	28	Search

2024	Hsa_circ_0008133 contributes to lung cancer progression by promoting glycolysis metabolism through the miR‐760/MEX3A axis Environmental Toxicology Shuhong Kang, Yunfeng Ni, Ke Lan, Feng Lv
2023	Investigation of the Potential Correlation Between RNA-Binding Proteins in the Evolutionarily Conserved MEX3 Family and Non-small-Cell Lung Cancer Molecular Biotechnology Ming Zhang, Linfeng Cao, Gouxin Hou, Xiaodong Lv, Jingjing Deng
2023	MEX3A induces the development of thyroid cancer via targeting CREB1 Cell Biology International Guoxun Feng, Penghui Wang, Hongyi Zhang, Shi Cheng, Ying Xing, Yuan Wang
2023	MEX3A determines in vivo hepatocellular carcinoma progression and induces resistance to sorafenib in a Hippo-dependent way Hepatology International Shiji Fang, Liyun Zheng, Xiaoxiao Chen, Xiaoju Guo, Yiming Ding, Ji Ma, Jiayi Ding, Weiqian Chen, Yang Yang, Minjiang Chen, Zhongwei Zhao, Jianfei Tu, Jiansong Ji
2022	Grass Carp Mex3A Promotes Ubiquitination and Degradation of RIG-I to Inhibit Innate Immune Response Frontiers in Immunology Zeyin Jiang, Zhichao Sun, Jihuan Hu, Dongming Li, Xiaowen Xu, Meifeng Li, Zhiqing Feng, Shanshan Zeng, Huiling Mao, Chengyu Hu
2022	MEX3A promotes nasopharyngeal carcinoma progression via the miR-3163/SCIN axis by regulating NF-κB signaling pathway Cell Death & Disease Xin-xin Xiang, Yong-liang Liu, Yi-fan Kang, Xiang Lu, Kai Xu
2022	SMYD2 epigenetically activates MEX3A and suppresses CDX2 in colorectal cancer cells to augment cancer growth Clinical and Experimental Pharmacology and Physiology Lizhen Pan, Yuejuan Fan, Lei Zhou
2022	Development and Validation of a Pyroptosis-Related Signature for Predicting Prognosis in Hepatocellular Carcinoma Frontiers in Genetics Jianfeng Ding, Xiaobo He, Wei Luo, Weiguo Zhou, Rui Chen, Guodong Cao, Bo Chen, Maoming Xiong
2021	MicroRNA-139-5p Suppresses Cell Malignant Behaviors in Breast Cancer through Targeting MEX3A Computational and Mathematical Methods in Medicine Jian Chu, Tangya Li, Lei Li, Huiwen Fan
2021	Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer Journal of Immunology Research Panpan Zhang, Tong Su, Shu Zhang
2021	Mex3a promotes oncogenesis through the RAP1/MAPK signaling pathway in colorectal cancer and is inhibited by hsa‐miR‐6887‐3p Cancer Communications Haixia Li, Jinghui Liang, Jiang Wang, Jingyi Han, Shuang Li, Kai Huang, Chuanyong Liu
2021	Systematic Construction and Validation of an RNA-Binding Protein-Associated Model for Prognosis Prediction in Hepatocellular Carcinoma Frontiers in Oncology Siyuan Tian, Jingyi Liu, Keshuai Sun, Yansheng Liu, Jiahao Yu, Shuoyi Ma, Miao Zhang, Gui Jia, Xia Zhou, Yulong Shang, Ying Han
2021	Bioinformatics Analysis Identifies IL6ST as a Potential Tumor Suppressor Gene for Triple-Negative Breast Cancer Reproductive Sciences Rong Jia, Yujie Weng, Zhongxian Li, Wei Liang, Yucheng Ji, Ying Liang, Pengfei Ning
2021	The effects of MEX3A knockdown on proliferation, apoptosis and migration of osteosarcoma cells Cancer Cell International Bangmin Wang, Zheping Hong, Chen Zhao, Qing Bi, Junhui Yuan, Jihang Chen, Yi Shen
2021	Discovery of key genes as novel biomarkers specifically associated with HPV-negative cervical cancer Molecular Therapy - Methods & Clinical Development Yi Liu, Yichi Xu, Wenxiao Jiang, Huihui Ji, Zhi-wei Wang, Xueqiong Zhu
2021	Expression and clinical significance of BDH1 in liver cancer Medicine Zhicheng Liu, Yanqing Li, Ying Liu, Dingquan Yang, Yan Jiao, Yunpeng Liu
2021	Mex-3 RNA binding MEX3A promotes the proliferation and migration of breast cancer cells via regulating RhoA/ROCK1/LIMK1 signaling pathway Bioengineered Li Yan, Hongjing Li, Wenbo an, Wei Wei, Xiaolei Zhang, Linlin Wang
2021	Oncogenic Potential of the Dual-Function Protein MEX3A Biology Marcell Lederer, Simon Müller, Markus Glaß, Nadine Bley, Christian Ihling, Andrea Sinz, Stefan Hüttelmaier
2021	MEX3A knockdown inhibits the tumorigenesis of colorectal cancer via modulating CDK2 expression Experimental and Therapeutic Medicine Xin Zhou, Shaojie Li, Tiexiang Ma, Jian Zeng, Huanyu Li, Xiang Liu, Feng Li, Bin Jiang, Ming Zhao, Zhuo Liu, Yiyu Qin
2021	Evaluation of FGFR1 as a diagnostic biomarker for ovarian cancer using TCGA and GEO datasets PeerJ Huiting Xiao, Kun Wang, Dan Li, Ke Wang, Min Yu
2020	GPSM2 Serves as an Independent Prognostic Biomarker for Liver Cancer Survival Technology in Cancer Research & Treatment Dingquan Yang, Fujian Ji, Yanqing Li, Yan Jiao, Xuedong Fang
2020	The Role of the RNA-Binding Protein Family MEX-3 in Tumorigenesis International Journal of Molecular Sciences Simon Jasinski-Bergner, André Steven, Barbara Seliger
2020	SOX11 promotes epithelial/mesenchymal hybrid state and alters tropism of invasive breast cancer cells eLife Erik Oliemuller, Richard Newman, Siu Man Tsang, Shane Foo, Gareth Muirhead, Farzana Noor, Syed Haider, Iskander Aurrekoetxea-Rodríguez, Maria dM Vivanco, Beatrice A Howard
2020	Evaluation of musculoskeletal phenotype of the G608G progeria mouse model with lonafarnib, pravastatin, and zoledronic acid as treatment groups Proceedings of the National Academy of Sciences Maria B. Cubria, Sebastian Suarez, Aidin Masoudi, Ramin Oftadeh, Pramod Kamalapathy, Amanda DuBose, Michael R. Erdos, Wayne A. Cabral, Lamya Karim, Francis S. Collins, Brian D. Snyder, Ara Nazarian
2020	The Prediction and Prognostic Significance of INPP5K Expression in Patients with Liver Cancer BioMed Research International Ruobing Wang, Yan Jiao, Yanqing Li, Siyang Ye, Guoqiang Pan, Shanshan Qin, Fang Hua, Yahui Liu
	Additional cited-by details will be shown when available from Crossref